Close-up of a scientist holding a tray of petri dishes with purple cultures, wearing gloves and safety gear.
Close-up of a scientist holding a tray of petri dishes with purple cultures, wearing gloves and safety gear.
Close-up of a scientist holding a tray of petri dishes with purple cultures, wearing gloves and safety gear.

Redefining Interventional Cardiology with Scalable AI Innovation

ComKardia is building an AI-powered decision-support platform for stent-based procedures. Using a patient-specific digital twin and scenario-based analysis, we help cardiologists plan treatment approaches with greater precision, efficiency, and consistency. The platform is designed to reduce variability and support scalable deployment across catheterization labs.

ComKardia Platform & Workflow

Fully Integrated Insight & Intelligence for Next Generation PCI

Clinical Problem

Clinical Problem

Clinical Problem

Percutaneous Coronary Intervention (PCI)

PCI is a common procedure for treating coronary artery disease.

PCI is a common procedure for treating coronary artery disease.

PCI is a common procedure for treating coronary artery disease.

Angiography-guided PCI results in 5-30% adverse clinical events (depending on procedure complexity), including heart attacks, hospital readmissions, repeat stent procedures, and death.

Angiography-guided PCI results in 5-30% adverse clinical events (depending on procedure complexity), including heart attacks, hospital readmissions, repeat stent procedures, and death.

Angiography-guided PCI results in 5-30% adverse clinical events (depending on procedure complexity), including heart attacks, hospital readmissions, repeat stent procedures, and death.

IVUS/OCT-Guided PCI

IVUS/OCT-guided PCI reduces adverse events by up to 50%. ​

IVUS/OCT-guided PCI reduces adverse events by up to 50%. ​

IVUS/OCT-guided PCI reduces adverse events by up to 50%. ​

Despite its benefits, global market penetration of IVUS/OCT in PCI remains below 15-20%.

Despite its benefits, global market penetration of IVUS/OCT in PCI remains below 15-20%.

Despite its benefits, global market penetration of IVUS/OCT in PCI remains below 15-20%.

A man in a white lab coat working at a computer, viewing a 3D model on the screen in a laboratory or office setting.
A man in a white lab coat working at a computer, viewing a 3D model on the screen in a laboratory or office setting.
A man in a white lab coat working at a computer, viewing a 3D model on the screen in a laboratory or office setting.

Solution

ComKardia is developing AI decision support for stent-based procedures. Using intravascular imaging and a patient-specific digital twin, the platform supports scenario-based planning for stent selection, sizing, and placement. The goal is faster, more consistent decisions that scale across cath labs.

IVUS/OCT integration in PCI processes through:

Automated lumen segmentation

Automated lumen segmentation

Automated lumen segmentation

Co-registration with angiography

Co-registration with angiography

Co-registration with angiography

3D reconstruction of anatomy

3D reconstruction of anatomy

3D reconstruction of anatomy

Fractional flow reserve (FFR)

Fractional flow reserve (FFR)

Fractional flow reserve (FFR)

Automatic plaque material characterization

Automatic plaque material characterization

Automatic plaque material characterization

Real-time clinical decision support system

Real-time clinical decision support system

Real-time clinical decision support system

ComKardia’s Competitive Edge

ComKardia is redefining PCI optimization through predictive and therapy-guiding intelligence. We combine physics-based digital twins, AI-driven simulation, and clinical validation to deliver a first-in-class decision support platform that transforms how interventional cardiologists plan and execute procedures.

Clinical Edge

Technology & IP Edge

Data, Partnerships & Market Edge

Predictive + prescriptive CDSS: Only system that not only predicts stent expansion but recommends lesion preparation strategies beyond NC balloons.

Extensive digital twin library: >100,000 validated simulations across calcified, fibrotic, and mixed plaques.

Multimodal imaging integration (IVUS/OCT + angiography) vs. static single-modality competitors.

Ongoing multicenter validation in U.S. and Europe.

Clinical Edge

Technology & IP Edge

Data, Partnerships & Market Edge

Predictive + prescriptive CDSS: Only system that not only predicts stent expansion but recommends lesion preparation strategies beyond NC balloons.

Extensive digital twin library: >100,000 validated simulations across calcified, fibrotic, and mixed plaques.

Multimodal imaging integration (IVUS/OCT + angiography) vs. static single-modality competitors.

Ongoing multicenter validation in U.S. and Europe.

Clinical Edge

Technology & IP Edge

Data, Partnerships & Market Edge

Predictive + prescriptive CDSS: Only system that not only predicts stent expansion but recommends lesion preparation strategies beyond NC balloons.

Extensive digital twin library: >100,000 validated simulations across calcified, fibrotic, and mixed plaques.

Multimodal imaging integration (IVUS/OCT + angiography) vs. static single-modality competitors.

Ongoing multicenter validation in U.S. and Europe.

© ComKardia, Inc.

Faster insights. Smarter interventions. Better outcomes.

© 2025 ComKardia, Inc. All rights reserved. The information provided on this website is for general informational purposes only and is not intended as professional, legal, medical, or financial advice. ComKardia, Inc. makes no representations or warranties of any kind, express or implied, regarding the accuracy, reliability, or completeness of any content. Use of this website is at your own risk. ComKardia, Inc. is not liable for any damages arising from your use of, or reliance on, the information contained herein. Links to third-party websites are provided for convenience only and do not constitute endorsement. By using this site, you agree to our Terms of Service and Privacy Policy.

© ComKardia, Inc.

Faster insights. Smarter interventions. Better outcomes.

© 2025 ComKardia, Inc. All rights reserved. The information provided on this website is for general informational purposes only and is not intended as professional, legal, medical, or financial advice. ComKardia, Inc. makes no representations or warranties of any kind, express or implied, regarding the accuracy, reliability, or completeness of any content. Use of this website is at your own risk. ComKardia, Inc. is not liable for any damages arising from your use of, or reliance on, the information contained herein. Links to third-party websites are provided for convenience only and do not constitute endorsement. By using this site, you agree to our Terms of Service and Privacy Policy.

© ComKardia, Inc.

Faster insights. Smarter interventions. Better outcomes.

© 2025 ComKardia, Inc. All rights reserved. The information provided on this website is for general informational purposes only and is not intended as professional, legal, medical, or financial advice. ComKardia, Inc. makes no representations or warranties of any kind, express or implied, regarding the accuracy, reliability, or completeness of any content. Use of this website is at your own risk. ComKardia, Inc. is not liable for any damages arising from your use of, or reliance on, the information contained herein. Links to third-party websites are provided for convenience only and do not constitute endorsement. By using this site, you agree to our Terms of Service and Privacy Policy.